<DOC>
	<DOCNO>NCT01772212</DOCNO>
	<brief_summary>The objective study confirm two formulation terbinafine ( tablet ) bioequivalent . Test product Xilatril® 250 mg ( Laboratorios Dermatológicos Darier ) reference product Lamisil® 250 mg ( Novartis ) . One tablet single dosage . The study prospective , open-label , randomize , crossover , single dose , 02 treatment , 02 sequence 02 period , fast condition . The population compose 30 healthy volunteer , gender , adult 18-50 year . The comparative bioavailability two formulation evaluate base statistical comparison relevant pharmacokinetic parameter , obtain data drug concentration blood .</brief_summary>
	<brief_title>Bioequivalence Study Terbinafine 250 mg</brief_title>
	<detailed_description />
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Terbinafine</mesh_term>
	<criteria>Males 1850 year . Healthy base comprehensive medical history , lab test , Chest xray , Electrocardiogram , negative test Hepatitis B C , HIV . Negative urine dope test . BMI 1926.5 kg/m2 . Lab test normal range +/ 10 % . Blood pressure 13990/8950 , heart rate 10055 , respiratory rate 2417 , temperature 37.535 °C . Nonsmoking least 10 hr study . Written informed consent . Hypersensitivity study medication relate drug . History cardiovascular , renal , hepatic , metabolic , gastrointestinal , neurologic , endocrine , hematopoietic , psychiatric organic condition . Requiring drug interfere minocycline pharmacokinetics . Exposed inducer inhibitor hepatic enzyme . Intake possible toxic drug 30 day study . Intake drug 14 day 7 halflives study . Hospitalization severe disease 60 day study . Receiving investigational drug study center 30 day study . Blood loss blood donation = &gt; 450 ml 60 day study . Recent history drug abuse include alcohol . Intake xanthine containing product 10 hr study . Intake grapefruit juice hotspice 10 hr study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Mexico</keyword>
	<keyword>terbinafine</keyword>
	<keyword>mycoses</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>